
About Elanco Animal Health
Elanco Animal Health (NYSE:ELAN) is a company dedicated to innovating and delivering products and services to prevent and treat diseases in animals, both companion and livestock. Their operations span across the development, manufacturing, and marketing of products for pets and farm animals, aiming to improve their health and performance. Elanco's projects often focus on addressing issues such as pet obesity, livestock disease management, and promoting overall animal well-being. The company's objectives revolve around enhancing the lives of animals, which in turn benefits the people who care for them and relies on their productivity. Elanco aims to be at the forefront of solving some of the world's most pressing animal health challenges through its comprehensive suite of products and services.
Snapshot
Operations
Produtos e/ou serviços de Elanco Animal Health
- Innovative vaccines for livestock and pets to prevent diseases, enhancing the health and welfare of animals worldwide.
- A comprehensive range of flea, tick, and heartworm prevention products for companion animals, ensuring a healthier, happier life for pets.
- Antibiotics and therapeutics aimed at treating a wide array of infections and diseases in both farm animals and pets, supporting global food security and animal welfare.
- Digital tools and services designed to monitor animal health and improve the efficiency of livestock management, contributing to sustainable agriculture practices.
- Nutritional products and supplements that improve the health, performance, and overall well-being of animals in various stages of life.
- Collaborations with governments and NGOs on animal health education programs, aiming to elevate public health standards through better veterinary practices.
equipe executiva do Elanco Animal Health
- Mr. Jeffrey N. SimmonsPresident, CEO & Director
- Dr. Ramiro Martin CabralExecutive VP & President of Elanco International
- Dr. Ellen de Brabander Ph.D.Executive Vice President of Research, Development & Regulatory Affairs
- Mr. Timothy J. BettingtonExecutive Vice President of Corporate Strategy & Market Development
- Mr. Robert M. VanHimbergenExecutive VP & CFO
- Mr. James M. MeerSenior VP & Chief Accounting Officer
- Mr. Chris KeeleySenior VP & Chief Information Officer
- Mr. David S. KinardExecutive Vice President of Human Resources, Corporate Communications & Administration
- Ms. Tiffany Ann KanagaVP of Investor Relations & ESG
- Ms. Shiv O'NeillExecutive Vice President, General Counsel & Corporate Secretary